Eric S Schafer Selected Research

Drug Therapy (Chemotherapy)

1/2022	Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
1/2022	Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
2/2018	Evaluation of aprepitant for acute chemotherapy-induced nausea and vomiting in children and adolescents with acute lymphoblastic leukemia receiving high-dose methotrexate.
2/2016	Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric S Schafer Research Topics

Disease

13	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 05/2011
6	Neoplasms (Cancer) 10/2022 - 01/2018
4	Leukemia 10/2022 - 01/2019
3	Lymphoma (Lymphomas) 10/2022 - 01/2022
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 01/2016
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 01/2018
2	Central Nervous System Neoplasms 01/2020 - 01/2018
1	Mucositis 10/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022
1	Tumor Lysis Syndrome 10/2022
1	Hypokalemia 10/2022
1	Febrile Neutropenia 10/2022
1	Eosinophilia 12/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Nausea 02/2018
1	Vomiting 02/2018
1	Neutropenia 01/2018
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 12/2017
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 02/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2016
1	Cytopenia 02/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2014

Drug/Important Bio-Agent (IBA)

5	Methotrexate (Mexate)FDA LinkGeneric 11/2020 - 01/2017
3	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2020 - 06/2014
3	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 06/2014
2	Decitabine FDA Link 10/2022 - 01/2022
2	Vorinostat FDA Link 10/2022 - 01/2022
2	2-mercaptopurineIBA 01/2019 - 06/2014
2	Thioguanine (Tioguanine)FDA Link 12/2017 - 06/2014
1	fludarabineIBA 10/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 10/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2022
1	TOR Serine-Threonine KinasesIBA 10/2022
1	temsirolimus FDA Link 10/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022
1	Alanine Transaminase (SGPT)IBA 10/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 12/2020
1	talazoparibIBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Aprepitant (Emend)FDA Link 02/2018
1	eribulin FDA Link 01/2018
1	Sirolimus (Rapamycin)FDA Link 02/2016
1	6-methylthiopurineIBA 06/2014
1	Matrix Metalloproteinases (MMPs)IBA 06/2014
1	NucleotidesIBA 06/2014

Therapy/Procedure

4	Therapeutics 10/2022 - 05/2011
4	Drug Therapy (Chemotherapy) 01/2022 - 02/2016
1	Hematopoietic Stem Cell Transplantation 01/2016